Pfizer Inc (NYSE:PFE) Q4 2017 Sentiment Change, Now at 1.06

May 16, 2018 - By Darrel Chase

Pfizer Inc. (NYSE:PFE) Corporate Logo

“Big money” Positions

“Big money sentiment for Pfizer Inc (NYSE:PFE) in Q4 2017 increased to 1.06, SEC filings reveal. So its up 0.10, from 2017Q3’s 0.96. 766 investment professionals increased and opened new positions, while 726 decreased and sold their stakes in Pfizer Inc so the sentiment improved. Funds own 4.07 billion shares, up from 4.06 billion shares in 2017Q3. Funds holding Pfizer Inc in top 10 changed to 112 from 139 for a decrease of 27. 51 Investors Sold All; 675 Reduced Holdings; 632 increased stakes while 134 investment professionals bought stakes.

Biggest Pfizer Inc Investors

Northeast Financial Consultants Inc owns 1.33 million shares in Pfizer Inc as of Q4 2017. Pfizer Inc’s shareholder Knott David M owns 933,276 shares as of Q4 2017. Also, New England Professional Planning Group Inc. reported 233,894 shares in Pfizer Inc equivalent to 10.51% of its stock exposure. Stuyvesant Capital Management revealed 138,265 shares position in Pfizer Inc. The Arkansas-based fund Foundation Resource Management Inc looks positive on Pfizer Inc, owning 1.26 million shares.

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide.The firm is worth $209.21 billion. It operates through two divisions, Pfizer Innovative Health and Pfizer Essential Health (EH).The P/E ratio is 9.94. The IH segment focuses on the development and commercialization of medicines and vaccines, and consumer healthcare products in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases, as well as consumer healthcare, such as dietary supplements, pain management, gastrointestinal, and respiratory and personal care.

Ticker’s shares touched $35.765 during the last trading session after 0.21% change.Currently Pfizer Inc. is uptrending after 2.43% change in last May 16, 2017. PFE has 6.89 million shares volume. PFE underperformed the S&P500 by 9.12%.

Pfizer Inc. (NYSE:PFE)’s quarterly earnings will be published on August, 7., Zacks reports. Last year’s EPS was $0.67, while now analysts expect change of 11.94 % up from current $0.75 EPS. If PFE’s EPS is $0.75 the profit will reach $4.39B for 11.92 P/E. Last quarter $0.77 EPS was reported. Analysts forecasts -2.60 % negative EPS growth this quarter.

Raymond James & Associates holds 0.61% or 9.22 million shs. Aviva Public Limited holds 5.18 million shs or 1.06% of its capital. Raymond James Tru Na invested 1.25% of its capital in Pfizer Inc. (NYSE:PFE). Moreover, Whitnell And has 0.16% invested in Pfizer Inc. (NYSE:PFE). North Star Inv Mngmt Corp, Illinois-based fund reported 154,163 shs. Shell Asset Co holds 1.24M shs. Moreover, Court Place Ltd Llc has 1.17% invested in Pfizer Inc. (NYSE:PFE). Fred Alger Mngmt invested in 98,348 shs or 0.02% of the stock. Howard Capital holds 0.45% of its capital in Pfizer Inc. (NYSE:PFE) for 85,191 shs. Lvw Advsr accumulated 104,886 shs. Mngmt Pro holds 4,524 shs or 0.07% of its capital. Royal Bancorp Of Scotland Public Ltd Company owns 6,225 shs or 0.05% of their US capital. 70,419 are owned by Aviance Ptnrs. 1.09M were accumulated by Rnc Limited Liability Corporation. Gould Asset Management Ca accumulated 0.43% or 27,201 shs.

Pfizer Inc. registered $17.75 million net activity with 0 insider purchases and 13 sales since December 15, 2017. Another trade for 50,000 shs valued at $1.84 million was made by LANKLER DOUGLAS M on Tuesday, March 13. HILL CHARLES H sold $1.52M worth of Pfizer Inc. (NYSE:PFE) or 42,393 shs on Tuesday, March 6. MACKENZIE ALEXANDER R had sold 6,750 shs worth $249,750 on Friday, December 15. READ IAN C also sold $4.76 million worth of Pfizer Inc. (NYSE:PFE) on Tuesday, May 1. On Saturday, February 24 $353,677 worth of Pfizer Inc. (NYSE:PFE) was sold by LUND-JURGENSEN KIRSTEN. On Monday, February 26 the insider SUSMAN SALLY sold $1.24M.

Pfizer Inc. (NYSE:PFE) Ratings Coverage

A total of 9 analysts rate Pfizer (NYSE:PFE) as follows: 3 “Buy”, 5 “Hold” and 1 “Sell”. Тherefore 33% are bullish. (NYSE:PFE) has 14 ratings reports on 16 May 2018 according to StockzIntelligence. On Tuesday, November 21 the stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by BMO Capital Markets. On Tuesday, January 16 Jefferies maintained the shares of PFE in report with “Hold” rating. On Wednesday, May 2 the stock of Pfizer Inc. (NYSE:PFE) earned “Outperform” rating by BMO Capital Markets. On Wednesday, January 31 the firm has “Market Perform” rating by Leerink Swann given. On Sunday, January 28 the firm earned “Hold” rating by SunTrust. On Friday, April 13 the firm earned “Hold” rating by Jefferies. The stock rating was maintained by BMO Capital Markets with “Buy” on Friday, December 15. In Wednesday, January 31 report Credit Suisse maintained the stock with “Neutral” rating. On Wednesday, January 31 Morgan Stanley maintained Pfizer Inc. (NYSE:PFE) rating. Morgan Stanley has “Overweight” rating and $43 target. On Thursday, April 5 the stock has “Equal-Weight” rating by Barclays Capital.

For more Pfizer Inc. (NYSE:PFE) news published briefly go to: Seekingalpha.com, 247Wallst.com, Streetinsider.com, Seekingalpha.com or Fool.com. The titles are as follows: “Pfizer: Buy This Dip?” published on May 03, 2018, “What to Look For in the Merck and Pfizer Reports Tuesday Morning” on April 30, 2018, “Pfizer (PFE) Announces FDA Approval for Biosimilar RETACRIT” with a publish date: May 15, 2018, “Pfizer Is A Definite Buy For 2018” and the last “Better Buy: Pfizer Inc. (PFE) vs. Merck (MRK)” with publication date: May 13, 2018.

Pfizer Inc. (NYSE:PFE) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.